Filing Details

Accession Number:
0001140361-22-029136
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-10 18:54:12
Reporting Period:
2022-08-08
Accepted Time:
2022-08-10 18:54:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439725 Biodesix Inc BDSX Services-Medical Laboratories (8071) 203986492
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476512 H Ryan Siurek 2970 Wilderness Place
Suite 100
Boulder CO 80301
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-08 5,484 $0.00 12,887 No 4 M Direct
Common Stock Disposition 2022-08-09 1,645 $2.53 11,242 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-08-08 1,927 $0.00 1,927 $0.00
Common Stock Restricted Stock Units Disposition 2022-08-08 3,557 $0.00 3,557 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,972 No 4 M Direct
14,227 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share").
  2. These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
  3. These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date.
  4. These Shares were sold automatically to cover taxes upon the vesting of RSUs.
  5. The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.